A detailed history of Met Life Investment Management, LLC transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 35,239 shares of NRIX stock, worth $698,789. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,239
Previous 35,071 0.48%
Holding current value
$698,789
Previous $731,000 8.21%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$18.93 - $25.69 $3,180 - $4,315
168 Added 0.48%
35,239 $791,000
Q2 2024

Aug 13, 2024

BUY
$12.02 - $21.3 $141,631 - $250,977
11,783 Added 50.6%
35,071 $731,000
Q1 2024

May 14, 2024

BUY
$7.77 - $15.66 $180,947 - $364,690
23,288 New
23,288 $342,000
Q2 2023

Apr 29, 2024

BUY
$8.7 - $13.28 $202,605 - $309,264
23,288 New
23,288 $232,000
Q2 2023

Aug 10, 2023

BUY
$8.7 - $13.28 $202,605 - $309,264
23,288 New
23,288 $232,000
Q1 2023

May 09, 2024

BUY
$8.56 - $13.26 $199,345 - $308,798
23,288 New
23,288 $207 Million
Q4 2022

Jun 14, 2023

BUY
$9.86 - $14.59 $229,619 - $339,771
23,288 New
23,288 $255,000
Q3 2022

Jun 14, 2023

BUY
$12.33 - $19.81 $287,141 - $461,335
23,288 New
23,288 $303,000
Q2 2022

May 10, 2024

BUY
$7.88 - $14.82 $36,389 - $68,438
4,618 Added 24.73%
23,288 $295,000
Q2 2022

Jun 20, 2023

BUY
$7.88 - $14.82 $183,509 - $345,128
23,288 New
23,288 $295,000
Q2 2022

Mar 22, 2023

BUY
$7.88 - $14.82 $36,389 - $68,438
4,618 Added 24.73%
23,288 $295,000
Q2 2022

Aug 11, 2022

BUY
$7.88 - $14.82 $36,389 - $68,438
4,618 Added 24.73%
23,288 $295,000
Q1 2022

May 10, 2024

BUY
$12.94 - $29.65 $241,589 - $553,565
18,670 New
18,670 $261,000
Q1 2022

Jun 20, 2023

BUY
$12.94 - $29.65 $241,589 - $553,565
18,670 New
18,670 $261,000
Q1 2022

Mar 22, 2023

BUY
$12.94 - $29.65 $89,169 - $204,318
6,891 Added 58.5%
18,670 $261,000
Q1 2022

May 12, 2022

BUY
$12.94 - $29.65 $89,169 - $204,318
6,891 Added 58.5%
18,670 $262,000
Q4 2021

Jun 21, 2023

BUY
$26.43 - $34.5 $311,318 - $406,375
11,779 New
11,779 $341,000
Q3 2021

Jun 21, 2023

BUY
$22.71 - $36.69 $267,501 - $432,171
11,779 New
11,779 $352,000
Q2 2021

May 17, 2024

BUY
$24.21 - $35.89 $54,932 - $81,434
2,269 Added 23.86%
11,779 $312,000
Q2 2021

Mar 22, 2023

BUY
$24.21 - $35.89 $54,932 - $81,434
2,269 Added 23.86%
11,779 $312,000
Q2 2021

Aug 16, 2021

BUY
$24.21 - $35.89 $54,932 - $81,434
2,269 Added 23.86%
11,779 $312,000
Q1 2021

May 17, 2024

SELL
$26.98 - $50.17 $371,730 - $691,242
-13,778 Reduced 59.16%
9,510 $295,000
Q1 2021

Jun 26, 2023

BUY
$26.98 - $50.17 $256,579 - $477,116
9,510 New
9,510 $296 Million
Q1 2021

Mar 22, 2023

BUY
$26.98 - $50.17 $119,278 - $221,801
4,421 Added 86.87%
9,510 $295,000
Q1 2021

May 14, 2021

BUY
$26.98 - $50.17 $119,278 - $221,801
4,421 Added 86.87%
9,510 $296,000
Q4 2020

Jun 22, 2023

BUY
$22.85 - $48.44 $116,283 - $246,511
5,089 New
5,089 $167,000
Q3 2020

May 24, 2024

SELL
$16.05 - $34.91 $292,093 - $635,327
-18,199 Reduced 78.15%
5,089 $178 Million
Q3 2020

Jun 26, 2023

BUY
$16.05 - $34.91 $81,678 - $177,656
5,089 New
5,089 $177,000
Q3 2020

Mar 22, 2023

SELL
$16.05 - $34.91 $292,093 - $635,327
-18,199 Reduced 78.15%
5,089 $177,000
Q3 2020

Nov 13, 2020

BUY
$16.05 - $34.91 $81,678 - $177,656
5,089 New
5,089 $178,000

Others Institutions Holding NRIX

About Nurix Therapeutics, Inc.


  • Ticker NRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,147,800
  • Market Cap $935M
  • Description
  • Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...
More about NRIX
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.